Pharmagen, Inc.

Equities

PHRX

US71715W1062

Delayed OTC Markets Other stock markets 12:46:06 14/06/2024 am IST			5-day change	1st Jan Change
0.000001 ^USD	0.00%		0.00%	0.00%

2015	Pharmagen, Inc. cancelled the transaction announced on November 30, 2012	CI
2014	Pharmagen, Inc. Announces Management Changes	CI

Pharmagen, Inc. announced that it has received $0.5 million in funding

April 01, 2014

On April 1, 2014, Pharmagen, Inc. closed the transaction. The company issued 100,000 shares to Bagel Boy Equity Group II, LLC in connection with the last tranche of the transaction. Bagel Boy Equity Group II, LLC has invested for 300,000 shares in the transaction.

The shares are redeemable by the company on ten trading days advance notice at two hundred percent of the purchase price.

Latest news about Pharmagen, Inc.

Pharmagen, Inc. cancelled the transaction announced on November 30, 2012	30/15/30	CI
Pharmagen, Inc. Announces Management Changes	03/14/03	CI
Pharmagen, Inc. Announces Executive Changes	11/14/11	CI
Pharmagen, Inc. Appoints Russell Skibsted as Executive Vice President and Chief Financial Officer	11/14/11	CI
Pharmagen Appoints Additional Members to its Board of Directors	29/14/29	CI
Pharmagen Recruits Frederick W. Mundt as Senior Vice President of Sales	06/14/06	CI
Pharmagen, Inc. Appoints Boyd Relac as Chief Operating Officer	29/14/29	CI
Pharmagen, Inc. announced that it has received $0.5 million in funding	01/14/01	CI
Pharmagen, Inc. Appoints Richard A. Wolpow as Member of Board of Directors and Interim-Chief Operating Officer	24/14/24	CI
Pharmagen, Inc. announced that it has received $0.15 million in funding.	24/14/24	CI
Pharmagen, Inc. Appoints Richard A. Wolpow as Chairman of the Board of Directors and Interim Chief Operating Officer	17/13/17	CI
Pharmagen, Inc. announced that it expects to receive $0.5 million in funding	12/13/12	CI
Pharmagen, Inc. Announces Consolidated Earnings Results for the Third Quarter and Nine Months Ended September 30, 2013	15/13/15	CI
Pharmagen Seeks Acquisitions	31/13/31	CI
Pharmagen, Inc. announced that it has received $0.04 million in funding from Asher Enterprises, Inc.	09/13/09	CI
Pharmagen, Inc. announced that it expects to receive $0.04 million in funding from Asher Enterprises, Inc.	01/13/01	CI
Pharmagen, Inc. announced that it has received $0.06 million in funding from Asher Enterprises, Inc.	19/13/19	CI
Pharmagen, Inc. announced that it expects to receive $0.06 million in funding from Asher Enterprises, Inc.	05/13/05	CI
Pharmagen, Inc. Announces Earnings Results for the First Quarter Ended March 31, 2013	15/13/15	CI
Pharmagen, Inc. Announces Consolidated Earnings Results for the Fiscal Year Ended December 31, 2012	01/13/01	CI
Pharmagen, Inc. announced that it has received $0.60 million in funding from Trafalgar Capital Advisors LTD.	29/13/29	CI
Pharmagen, Inc. announced that it expects to receive $2 million in funding from Trafalgar Capital Advisors LTD.	28/13/28	CI
Sunpeaks Ventures, Inc. will Change its Ticker to PHRX from SNPK	15/13/15	CI
Sunpeaks Ventures, Inc. Creates New Operating Unit, Pharmagen Nutraceuticals	14/13/14	CI
Sunpeaks Ventures, Inc. has Changed its Name to Pharmagen, Inc	14/13/14	CI

Chart Pharmagen, Inc.

Duration

Period

More charts

Company Profile

Sector

More about the company